MedPath

Mental Healthcare in Older Adults With Schizophrenia

Conditions
Schizophrenia
Chronic Psychiatric Disorder
Interventions
Other: Data collection
Registration Number
NCT02884739
Lead Sponsor
CHU de Reims
Brief Summary

As in the general population, there is a gradual and steady increase in life expectancy of patients with schizophrenia. But this increase is at a smaller scale, with a rate of premature death that is still 2 to 3 times higher than that found in the general population. This excessive early mortality is explained by an overrepresentation of suicide deaths, but also a higher prevalence of somatic diseases, mainly cardiovascular. But today there are only very few epidemiological data on the mortality of patients with schizophrenia, including those aged over 60 years. What are the sociodemographic and clinical characteristics (psychiatric and somatic) of these schizophrenic elderly patients? Do they benefit from a somatic follow-up adequate and systematic? What are their levels of social independence and of quality of life? the answers these questions and the description of the offer of geriatric care and of psychiatric care currently provided by different sectors of psychiatry in France is an indispensable prerequisite for any project to improve the quality of life, state of health and mortality of older patients with schizophrenia.

Detailed Description

Evaluate prospectively over 5 years, the rates and causes of mortality in a cohort of schizophrenic patients older than 60 years, followed by adult psychiatry sectors, compared to those patients matched for sex and age and monitored by the same sectors for a chronic psychiatric disorder other than schizophrenia

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
685
Inclusion Criteria
  • Men or women aged than 60 years with a diagnosis of schizophrenia, according to the DSM-IV criteria
  • Men or women aged than 60 years with chronic psychiatric disorder other than schizophrenia
  • Patients consenting to participate to the study
  • Patients enrolled in the national healthcare insurance program
Exclusion Criteria

-Disease affecting the central nervous system

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
schizophreniaData collection-
chronic psychiatric disorder other than schizophreniaData collection-
Primary Outcome Measures
NameTimeMethod
Death5 years

Death of any causes

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu de Reims

🇫🇷

Reims, France

© Copyright 2025. All Rights Reserved by MedPath